229 related articles for article (PubMed ID: 31706985)
1. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
Allaire M; Cadranel JF; Nguyen TTN; Garioud A; Zougmore H; Heng R; Perignon C; Ollivier-Hourmand I; Dao T
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):264-274. PubMed ID: 31706985
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
[TBL] [Abstract][Full Text] [Related]
3. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
Satlin MJ; Walsh TJ
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
[TBL] [Abstract][Full Text] [Related]
6. Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies.
Liu J; Gao Y; Wang X; Qian Z; Chen J; Huang Y; Meng Z; Lu X; Deng G; Liu F; Zhang Z; Li H; Zheng X
Yonsei Med J; 2020 Feb; 61(2):145-153. PubMed ID: 31997623
[TBL] [Abstract][Full Text] [Related]
7. New antibiotic strategies in patients with cirrhosis and bacterial infection.
Fernández J; Acevedo J
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1495-500. PubMed ID: 26465070
[TBL] [Abstract][Full Text] [Related]
8. Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials.
Maraolo AE; Scotto R; Zappulo E; Pinchera B; Schiano Moriello N; Nappa S; Buonomo AR; Gentile I
Expert Rev Anti Infect Ther; 2020 Mar; 18(3):191-202. PubMed ID: 32011191
[No Abstract] [Full Text] [Related]
9. Pancreatic infections.
Golkar FC; Rosemurgy AS
Arch Surg; 2011 May; 146(5):619. PubMed ID: 21739658
[No Abstract] [Full Text] [Related]
10. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis.
Alexopoulou A; Papadopoulos N; Eliopoulos DG; Alexaki A; Tsiriga A; Toutouza M; Pectasides D
Liver Int; 2013 Aug; 33(7):975-81. PubMed ID: 23522099
[TBL] [Abstract][Full Text] [Related]
11. Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosis.
Pouriki S; Vrioni G; Sambatakou H; Alexopoulou A; Vasilieva L; Mani I; Tsakris A; Dourakis SP
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):127-134. PubMed ID: 28963603
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.
Santoro-Lopes G; de Gouvêa EF
World J Gastroenterol; 2014 May; 20(20):6201-10. PubMed ID: 24876740
[TBL] [Abstract][Full Text] [Related]
13. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
Noskin GA
Ann Acad Med Singap; 2001 May; 30(3):320-31. PubMed ID: 11455748
[TBL] [Abstract][Full Text] [Related]
14. Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis.
Kohlenberg A; Schwab F; Meyer E; Behnke M; Geffers C; Gastmeier P
J Hosp Infect; 2009 Nov; 73(3):239-45. PubMed ID: 19804919
[TBL] [Abstract][Full Text] [Related]
15. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.
Righi E
World J Gastroenterol; 2018 Oct; 24(38):4311-4329. PubMed ID: 30344417
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
Casellas JM
Rev Panam Salud Publica; 2011 Dec; 30(6):519-28. PubMed ID: 22358396
[TBL] [Abstract][Full Text] [Related]
18. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
[TBL] [Abstract][Full Text] [Related]
19. The challenges of multi-drug-resistance in hepatology.
Fernández J; Bert F; Nicolas-Chanoine MH
J Hepatol; 2016 Nov; 65(5):1043-1054. PubMed ID: 27544545
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
